Evidence map›Paper›PMID 29422601›Full record

ArticleScientific reports2018

No evidence of ongoing evolution in replication competent latent HIV-1 in a patient followed up for two years.

Hoi Ping Mok, Nicholas J Norton, Jack C Hirst, Axel Fun, Mikaila Bandara, Mark R Wills, Andrew M L Lever

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. HIV Infected T Cells Can ProliferateFrontiers in microbiology · 2019
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hoi Ping MokDepartment of Medicine, University of Cambridge, Cambridge, UK.ORCID 0000-0003-1402-7194
Nicholas J NortonDepartment of Medicine, University of Cambridge, Cambridge, UK.
Jack C HirstDepartment of Medicine, University of Cambridge, Cambridge, UK.ORCID 0000-0003-4325-9867
Axel FunDepartment of Medicine, University of Cambridge, Cambridge, UK.ORCID 0000-0001-7891-2980
Mikaila BandaraDepartment of Medicine, University of Cambridge, Cambridge, UK.
Mark R WillsDepartment of Medicine, University of Cambridge, Cambridge, UK.
Andrew M L LeverDepartment of Medicine, University of Cambridge, Cambridge, UK. amll1@medschl.cam.ac.uk.

Funding

Medical Research Council MR/M003515/1Medical Research Council MR/N02043X/1
6 · The paper itself

Abstract

The persistence of infected T cells harbouring intact HIV proviruses is the barrier to the eradication of HIV. This reservoir is stable over long periods of time despite antiretroviral therapy. There has been controversy on whether low level viral replication is occurring at sanctuary sites periodically reseeding infected cells into the latent reservoir to account its durability. To study viral evolution in a physiologically relevant population of latent viruses, we repeatedly performed virus outgrowth assays on a stably treated HIV positive patient over two years and sequenced the reactivated latent viruses. We sought evidence of increasing sequence pairwise distances with time as evidence of ongoing viral replication. 64 reactivatable latent viral sequences were obtained over 103 weeks. We did not observe an increase in genetic distance of the sequences with the time elapsed between sampling. No evolution could be discerned in these reactivatable latent viruses. Thus, in this patient, the contribution of low-level replication to the maintenance of the latent reservoir detectable in the blood compartment is limited.

Indexed as

Virus ReplicationCD4-Positive T-LymphocytesEvolution, MolecularHIV-1HIV InfectionsHumansMaleMiddle AgedViral LoadVirus Latency

Identifiers

PMID29422601
PMCPMC5805784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.